# Metformin and Systemic Inflammation in HIV

> **NCT03774108** · PHASE4 · UNKNOWN · sponsor: **Hospital Civil de Guadalajara** · enrollment: 40 (actual)

## Conditions studied

- PreDiabetes
- HIV-1-infection

## Interventions

- **DRUG:** Metformin Hydrochloride 850 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03774108
- **Lead sponsor:** Hospital Civil de Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-15
- **Primary completion:** 2019-12-20
- **Final completion:** 2020-01-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774108, "Metformin and Systemic Inflammation in HIV". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03774108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*